ALABISO, Oscar
 Distribuzione geografica
Continente #
EU - Europa 3.437
NA - Nord America 3.395
AS - Asia 1.771
SA - Sud America 163
Continente sconosciuto - Info sul continente non disponibili 33
AF - Africa 32
OC - Oceania 5
Totale 8.836
Nazione #
US - Stati Uniti d'America 3.325
RU - Federazione Russa 762
IE - Irlanda 734
SG - Singapore 620
CN - Cina 479
DE - Germania 456
SE - Svezia 360
UA - Ucraina 298
HK - Hong Kong 272
IT - Italia 256
FR - Francia 199
FI - Finlandia 190
VN - Vietnam 189
BR - Brasile 126
GB - Regno Unito 77
IN - India 57
CA - Canada 41
KR - Corea 28
PL - Polonia 22
IR - Iran 20
BD - Bangladesh 18
AR - Argentina 17
BE - Belgio 16
MX - Messico 15
ID - Indonesia 12
TR - Turchia 12
ES - Italia 11
AT - Austria 10
CZ - Repubblica Ceca 10
LT - Lituania 10
JP - Giappone 9
NL - Olanda 9
EC - Ecuador 8
ZA - Sudafrica 8
CO - Colombia 7
EU - Europa 7
IQ - Iraq 7
PK - Pakistan 7
AE - Emirati Arabi Uniti 5
AU - Australia 5
EG - Egitto 4
ET - Etiopia 4
JM - Giamaica 4
JO - Giordania 4
KE - Kenya 4
KZ - Kazakistan 4
PH - Filippine 4
UZ - Uzbekistan 4
VE - Venezuela 4
BJ - Benin 3
KG - Kirghizistan 3
PT - Portogallo 3
TH - Thailandia 3
TN - Tunisia 3
AL - Albania 2
BB - Barbados 2
CH - Svizzera 2
DO - Repubblica Dominicana 2
LB - Libano 2
MA - Marocco 2
MD - Moldavia 2
MU - Mauritius 2
MY - Malesia 2
SA - Arabia Saudita 2
TT - Trinidad e Tobago 2
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BO - Bolivia 1
CR - Costa Rica 1
CY - Cipro 1
DK - Danimarca 1
DZ - Algeria 1
GE - Georgia 1
GR - Grecia 1
GT - Guatemala 1
HN - Honduras 1
IL - Israele 1
LV - Lettonia 1
NP - Nepal 1
PA - Panama 1
PS - Palestinian Territory 1
QA - Qatar 1
RO - Romania 1
RW - Ruanda 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
TW - Taiwan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 8.811
Città #
Dublin 733
Jacksonville 527
San Jose 333
Dearborn 277
Hong Kong 270
Ashburn 209
Singapore 205
Council Bluffs 165
Wilmington 157
Chandler 136
Beijing 126
Moscow 109
San Mateo 93
Lawrence 92
Princeton 92
Ann Arbor 90
Lauterbourg 74
Los Angeles 71
Andover 65
Hanoi 54
Dallas 51
Bremen 48
Buffalo 48
Ho Chi Minh City 45
Piemonte 42
New York 40
Santa Clara 39
Columbus 32
Orem 32
Munich 31
Grafing 29
Seoul 26
Torino 26
São Paulo 25
Brooklyn 21
Houston 20
Redondo Beach 18
Warsaw 18
Chicago 17
Boardman 16
Guangzhou 16
Nanjing 16
Rome 16
Boston 15
Brussels 15
Chennai 15
Helsinki 15
Nuremberg 15
Milan 14
Haiphong 13
Tianjin 13
Dong Ket 12
Hefei 12
Norwalk 12
Stockholm 12
Toronto 12
Woodbridge 11
Atlanta 10
Da Nang 10
Kunming 10
Manchester 10
Phoenix 10
Brno 9
Frankfurt am Main 9
Philadelphia 9
Tokyo 9
Augusta 8
Denver 8
Montreal 8
Poplar 8
Shanghai 8
West Jordan 8
Zanjan 8
Hangzhou 7
Leawood 7
London 7
Monmouth Junction 7
Mumbai 7
Barnet 6
Düsseldorf 6
Fuzhou 6
Jakarta 6
Shenzhen 6
Turin 6
Dalian 5
Johannesburg 5
Nanchang 5
San Francisco 5
Addis Ababa 4
Amman 4
Ankara 4
Ardabil 4
Bari 4
Brescia 4
Charleston 4
Honolulu 4
Hải Dương 4
Jinan 4
Kingston 4
Lahore 4
Totale 5.017
Nome #
Economic burden of patients affected by non-small cell lung cancer (NSCLC): the LIFE study 166
Carcinoma sarcomatoide della prostata: caso clinico 155
Autophagy and thyroid carcinogenesis: genetic and epigenetic links 150
Resveratrol inhibits IL-6-induced ovarian cancer cell migration through epigenetic up-regulation of autophagy 148
PTEN deficiency and mutant p53 confer glucose-addiction to thyroid cancer cells: impact of glucose depletion on cell proliferation, cell survival, autophagy and cell migration. 145
Activity and safety of RAD001 (everolimus) in patients affected by biliary tract cancer progressing after prior chemotherapy: a phase II ITMO study. 144
Integrins in T Cell Physiology 142
Case report : Herceptin e carcinoma mammario 141
Aberrant somatic hypermutation in primary mediastinal large B-cell lymphoma 125
First-Line Bevacizumab-Based Therapy in Advanced Non-Squamous Non-Small-Cell Lung Cancer: Analysis of the Italian Patients Enrolled in the SAiL Study 122
Circannual variation of efficacy outcomes in patients with newly diagnosedmetastatic colorectal cancer and treated with first-line chemotherapy 122
Adjuvant chemotherapy of pT1a and pT1b breast carcinoma: results from the NEMESI study 120
Analysis of immunoglobulin heavy and light chain variable genes in post-transplant lymfoproliferative disorders 120
PTEN regulates plasma membrane expression of glucose transporter 1 and glucose uptake in thyroid cancer cells. 118
Comparison of the Tolerability Profile of Controlled-Release Oral Morphine and Oxycodone for Cancer Pain Treatment. An Open-Label Randomized Controlled Trial 117
Case report : Metastatic melanoma 116
Safety and activity of docetaxel and trastuzumab in HER2 overexpressing metastatic breast cancer. a pilot phase II study 113
Ependimoma anaplastico della regione dorso lombare in adulto: caso clinico 112
Combined regional and systemic chemotherapy by a mini-invasive approach for the treatment of colorectal liver metastases 111
Mutation analysis of KRAS in primary colorectal cancer and matched metastases by means of highly sensitivity molecular assay. 111
Preliminary safety and efficacy of first-line pertuzumab combined with trastuzumab and taxane therapy for HER2-positive locally recurrent or metastatic breast cancer (PERUSE). 111
CARCINOMA DEL COLON METASTATICO: CASE REPORT 110
Association between ultrarapid CYP2D6 polymorphisms and adverse drug reactions among women with breast cancer treated with tamoxifen 109
Disparity in the 'time to patient access' to new anti-cancer drugs in Italian regions. Results of a survey conducted by the Italian Society of Medical Oncology (AIOM) 107
Migrazione epatica di cellule A-LAK autologhe espanse e marcate con 111Indio ex-vivo in pazienti affetti da metastasi epatiche di carcinoma del grosso intestino 107
Mutation analysis of the EGFR gene and downstream signalling pathway in histologic samples of malignant pleural mesothelioma. 107
Localizzazione gengivale metastatica in paziente affetta da carcinoma colorettale avanzato: caso clinico 106
Venous thromboembolism in lung cancer: retrospective analysis of data in outpatients treated at oncology department of Novara 106
Limits of aortic stop flow infusion chemotherapy in the treatment of advanced cancer 104
Docetaxel and Oxaliplatin in weekly administration in solid tumors: dose finding study 104
Experience of integration among different lists in oncological equipe : doctors, nurses , psychologists 101
The role of lung metastasis resection in improving outcome of colorectal cancer patients: results from a large retrospective study 101
Risposta completa prolungata e terapia con sunitinib in paziente affetto da carcinoma a cellule renali metastatico 101
Autophagy inhibition enhances anthocyanin-induced apoptosis in hepatocellular carcinoma 100
Venous thromboembolism in non-small cell lung cancer patients: retrospective analysis of cases treated at the Oncology Day Hospital of Novara, Italy 100
Carcinoma del colon metastatico: caso clinico. Bevacizumab e Capecitabina nella pratica clinica. Current therapeutics. Adis Milano 2006 99
RMN DWIBS (Diffusion Weighet Body Imaging With Background Body Signal Suppression) WHOLE BODY in oncologia: studio osservazionale risultati preliminary 99
FISH in triple-negative breast cancer: a possible strategy for the future? 99
Neoplasia a primitività ignota: case report 99
Expression and Clinical Significance of the Autophagy Proteins BECLIN 1 and LC3 in Ovarian Cancer 99
A phase II study of three-weekly docetaxel and weekly trastuzumab in HER2-overexpressing advanced breast cancer (ABC) 98
The incidence of venous thromboembolism (VTE) in metastatic colorectal cancer (mCRC) patients 98
FULD Combination Given as Hepatic Artery Infusion (HAI) in Colon-Rectal Liver Metastases (CLM) by a Percutaneously Placed Port-a-Cath (PAC) in Elderly or Unfit Patients (EUP) 97
Tumore misto mülleriano dell’endometrio: case report 97
Singola localizzazione paravertebrale in seminoma testicolare: un caso clinico 96
Preliminary Results of a Phase II Study with Gemcitabine and Continuous Infusion 5FU in Patients with Advanced or Metastatic Pancreatic Cancer 95
Gemcitabine in vitro activity on hepatocellular carcinoma: basic pharmacological parameters and drug combinations 95
Continuous 5-fluorouracil infusion plus long acting octreotide in advanced well-differentiated neuroendocrine carcinomas. A phase II trial of the Piemonte oncology network 95
TCFW:5FUpvi in combination with weekly docetaxel and CDDP in advanced gastric cancer, a phase I-II study: the dose finding step."Rete Oncologica Piemontese" 92
Differences in the availability of new anti-cancer drugs for Italian patients treated in different regions. Results of analysis conducted by the Italian Society Of Medical Oncology 92
Final report of a phase II trial of Gemcitabine (GEM) with 5FU continous infusion (CI) in the treatment of advanced pancreatic cancer (APC) 91
Medical treatment choices for patients affected by advanced NSCLC in routine clinical practice: Results from the Italian observational "SUN" (Survey on the lUng cancer maNagement) study. Lung Cancer 90
High serum levels of Transforming Growth Factor-beta1, Interleukin-10 and Vascular Endothelial Growth Factor in pancreatic adenocarcinoma patients 89
Hepatic arterial infusion chemotherapy for Production and pro-apoptotic activity of soluble CD95 ligand in pancreatic carcinoma 89
Production and pro-apoptotic activity of soluble CD95 ligand in pancreatic carcinoma 87
Observational study on quality of life, safety, and effectiveness of first-line cetuximab plus chemotherapy in KRAS wild-type metastatic colorectal cancer patients: the ObservEr Study 87
Tossicita’ da trattamento con Bevacizumab: l’esperienza della S.C.D.U. Oncologia medica di Novara 86
p27Kip1 is inactivated in human colorectal cancer by cytoplasmic localization associated with activation of Akt/PKB 86
Docetaxel plus androgen deprivation withdrawal may restore sensitivity to luteinizing hormone-releasing hormone analog therapy in castration-resistant prostate cancer patients 86
Phase I trial of tomudex ( TOM ) + protracted – venous- infusion 5-fluorouracil (PVI-5FU ) in advanced ileal and colorectal cancer 85
Impact of use of oral anticancer drugs on activity of Italian oncology practices: results of a survey conducted by the Italian Society of Medical Oncology (AIOM) 85
Pelvic Intra-Arterial Infusion via Percutaneous Arterial Port for Locoregional Chemotherapy of Cancer Relapses 84
Port in oncology practice: 3-monthly locking with normal saline for catheter maintenance, a preliminary report 84
Phase II study of pemetrexed in combination with carboplatin in patients with malignant pleural mesothelioma (MPM) 82
Tolerability and compliance to chemotherapy in psychiatric patients with cancer 80
Whole-body diffusion-weighted magnetic resonance imaging in the staging of oncological patients: comparison with positron emission tomography computed tomography (PET-CT) in a pilot study 78
Inguinal sentinel node in anal neoplasms 77
Seminoma del testicolo: localizzazione paravertebrale di malattia: caso clinico 76
Palliative treatment for elderly patients with colon cancer in ten Italian medical oncology units 76
Efficacy and Safety of RAD001 as Second Line Therapy in Biliary Tract Cancer (BTC) Patients (pts) – a Phase II I.T.M.O. (Italian Trials in Medical Oncology) Group Study 76
Side effects associated with ultrarapid cytochrome P450 2D6 genotype among women with early stage breast cancer treated with tamoxifen 74
Interim Results of a Phase II Trial of Raltitrexed (RAL) + Protracted-Venous-Infusion-5-Fluorouracil (PVI-5-FU) in Advanced Colorectal Cancer 73
The CAP-CR study: direct medical costs in Italian metastatic colorectal cancer patients on first-line infusional 5-fluorouracil or oral capecitabine 73
Feasibility of fludarabine based treatment for lymphoproliferative disorders in patients over eighty years old 71
Tolerability and compliance to chemotherapy in neuropsychiatric patients 71
Intra-arterial continuous infusion for treatment of pancreatic and biliary tract cancer 69
Involvement of autophagy in ovarian cancer: a working hypothesis 68
Increased detection sensitivity for KRAS mutations enhances the prediction of anti-EGFR monoclonal antibody resistance in metastatic colorectal cancer 68
Preliminary results of phase II trial with combination of gemcitabine and oxaliplatin in elderly patients with advanced NSCLC 67
Topotecan (T) and ifosfamide (I) as salvage treatment in advanced ovarian cancer 67
Stage IV gastric cancer and FOLFOX 6. Case report 66
The role of haemoglobin level in predicting the response to first-line chemotherapy in advanced colorectal cancer patients 66
Safety and activity of docetaxel and trastuzumab in HER2 overexpressing metastatic breast cancer: a pilot phase II study 65
Prognostic significance of changes in CA 15-3 serum levels during chemotherapy in metastatic breast cancer patients 65
Riflessione sugli aspetti psicosociali in oncologia 65
Impact of hemoglobin levels in psychiatric patients with cancer 64
Prophylactic effect of reduced glutathione (GSH) on oxaliplatin chronic cumulative neurotoxicity (CCN) 63
Two cases of secondary soft tissue sarcomas after radiotherapy and radiochemiotherapy 61
Pericardial metastases in a long-surviving patient with sigmoid carcinoma 60
Prospective study on prognostic significance of DNA ploidy and Ki-67 expression in colorectal cancer 60
Secondary neoplasms: our experience 59
Variation in gynecological oncology follow-up practice: attributable to cancer centers or to patient characteristics? A Piedmont Regional Oncology Network Study 57
The role of hemoglobin level in predicting the response to first-line chemotherapy in advanced colorectal cancer (ACC) patients 54
null 34
Totale 8.836
Categoria #
all - tutte 43.563
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.563


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022650 0 8 138 57 35 1 91 13 40 17 134 116
2022/20231.360 107 37 62 36 115 123 37 73 711 3 36 20
2023/2024365 27 19 40 4 81 2 88 4 4 10 28 58
2024/2025938 23 28 50 12 30 123 120 47 260 78 32 135
2025/20263.017 128 82 205 296 303 254 480 544 242 298 139 46
2026/2027242 72 170 0 0 0 0 0 0 0 0 0 0
Totale 8.836